Study Design Stanford University研究设计斯坦福大学.pptVIP

The Effect of Celecoxib, a Cyclooxegenase-2 Inhibitor, In Familial Adenematous Polyposis Gideon Steinbach, M.D., Ph. D., Patrick Lynch, M.D., J.D., Robin K.S. Phillips, M.B., B.S., Marina H. Wallace, M.B., B.S., Ernest Hawk, M.D., M.P.H., Gary B. Gordon, M.D., Ph.D., Naoki Wakabayashi, M.D., Ph.D., Brian Saunders, M.D., Yu Shien, Ph.D., Takashi Fujimara, M.D., Li-Kuo Su, Ph.D., and Bernard Levin, M.D. Why Familial Adenomatous Polyposis? Human colon cancer develops from normal mucosa to adenomatous polyps to carcinoma Patients with FAP as a result of germ-line mutations in the Adenomatous Polyp